Login
$EWTX
$43.68 -$2.25 (4.9%) Live

Insider Transactions

What Edgewise Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 0
Sells 1 17
Total trades 3 34

Shares traded

3 months 12 months
Acquired 11,245 467,691
Disposed 4,442 459,472
Net activity +6,803 +8,219

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Nofi Michael Chief Financial Officer Nov 10 Sale for tax withholding · S −4,442 $45.43 −$202K 6,495
Nofi Michael Chief Financial Officer Nov 10 Exercise / conversion · M +10,937 — — 10,937
Fox Jonathan C Director Oct 01 Grant / award · A +308 — — 25,141
Koch Kevin President and CEO Aug 12 Sale for tax withholding · S −913 $44.33 −$40.5K 52,488
Koch Kevin President and CEO Aug 12 Sale for tax withholding · S −8,276 $43.66 −$361K 53,401
Koch Kevin President and CEO Aug 12 Sale for tax withholding · S −8,782 $43.64 −$383K 61,677
Koch Kevin President and CEO Aug 12 Exercise / conversion · M +21,875 — — 70,459
Koch Kevin President and CEO Aug 12 Exercise / conversion · M +17,969 — — 48,584
Fox Jonathan C Director Jul 01 Grant / award · A +319 — — 24,833
Russell Alan J Chief Scientific Officer Jul 01 Open-market sale · S −69,648 $39.41 −$2.74M 24,555
Russell Alan J Chief Scientific Officer Jul 01 Open-market sale · S −130,352 $39.41 −$5.14M 94,203
Russell Alan J Chief Scientific Officer Jul 01 Exercise / conversion · M +69,648 $0.18 +$12.5K 224,555
Russell Alan J Chief Scientific Officer Jul 01 Exercise / conversion · M +130,352 $0.45 +$58.7K 154,907
Donovan Joanne M. CMO May 05 Disclosed 10b5-1 sale · S −50,000 $38.57 −$1.93M 4,367
Donovan Joanne M. CMO May 05 Exercise / conversion · M +50,000 $7.08 +$354K 54,367
Donovan Joanne M. CMO May 04 Disclosed 10b5-1 sale · S −5,230 $31.29 −$164K 4,367
Donovan Joanne M. CMO Apr 01 Disclosed 10b5-1 sale · S −28,662 $32.31 −$926K 9,597
Donovan Joanne M. CMO Apr 01 Exercise / conversion · M +28,662 $7.08 +$203K 38,259
Fox Jonathan C Director Apr 01 Grant / award · A +339 — — 24,514
Donovan Joanne M. CMO Mar 31 Disclosed 10b5-1 sale · S −21,338 $32.12 −$685K 9,597

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support